Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Racial Disparities Common in Stroke Treatment

October 12, 2010 6:00 am | by Lauran Neergaard | News | Comments

When her stroke hit, Edna Wooten somehow stopped her car. Then her grown daughter ignored her slurred protests and raced her to the hospital - in time for a drug to dissolve the blood clot causing her stroke.

TOPICS:

Geron Testing Stem Cell Treatment in Humans

October 12, 2010 5:54 am | by Damian Troise | News | Comments

Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord injuries, marking the first time such a drug has been used on a human.

TOPICS:

Supreme Court Hearing Vaccine Arguments

October 12, 2010 5:52 am | News | Comments

Parents who say their daughter allegedly suffered serious health problems from a childhood vaccine are trying to persuade the Supreme Court to allow them to sue the manufacturer.

TOPICS:
Advertisement

Pfizer Buying King for $3.6B

October 12, 2010 5:48 am | News | Comments

Pfizer Inc., the world's largest pharmaceutical company by revenue, said it will buy pain drug maker King Pharmaceuticals Inc. for $3.6 billion in cash.

TOPICS:

Digital Microscope

October 11, 2010 11:09 am | Product Releases | Comments

Keyence Corp.’s VHX-1000 digital microscope successfully integrates many of the optical properties and functionalities of stereoscopes, measuring microscopes, and scanning electron microscopes into an all-in-one.

TOPICS:

Optical/SEM Microscope

October 11, 2010 11:03 am | Product Releases | Comments

JEOL USA, Inc. and the Japanese AIST have developed the ClairScope, a tool that couples optical microscopy with an atmospheric scanning electron microscope in an open culture system that retains the samples’ native state while under study.

TOPICS:

Optical Microscope Accessory

October 11, 2010 10:57 am | Product Releases | Comments

VivaTome, an optical microscope accessory from Carl Zeiss and Aurox Ltd., addresses the problem of unwanted blurred information being included with the primary in-focus information from.

TOPICS:

Reading List

October 11, 2010 10:28 am | by Rita C. Peters, Editorial Director | Articles | Comments

This month, I am pleased to share with you some features that are in our magazine, and some that are not. Editors are frequently frustrated by the physical limitations of the printed page.

TOPICS:
Advertisement

Final Rule on Clinical Trial Safety Information

October 11, 2010 10:24 am | News | Comments

In late September, the U.S. Food and Drug Administration issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.

TOPICS:

Reading More from Microplates

October 11, 2010 10:12 am | by Mike May, Contributing Editor | Articles | Comments

Many articles describe assays that work in multi-well plates, but without the technology to read the results these assays are of limited benefit to the drug discovery and development process.

TOPICS:

Disposable Dialysis Plates

October 11, 2010 8:39 am | Product Releases | Comments

Harvard Apparatus offers the 192-Well DispoEquilibrium DIALYZERS that analyze up to 96 samples simultaneously on disposable dialysis plates.

TOPICS:

Personal Microarray System

October 11, 2010 8:37 am | Drug Discovery & Development | Product Releases | Comments

Affymetrix has launched the GeneAtlas System to make Affymetrix microarrays accessible to all life science researchers.

TOPICS:

ImmunoGen Collaborating With Novartis

October 11, 2010 8:29 am | News | Comments

ImmunoGen, Inc. announced that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.

TOPICS:

Exelixis Working With BMS

October 11, 2010 8:24 am | News | Comments

Exelixis, Inc. has entered into two collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.

TOPICS:

New Alzheimer's Definition to Aid in Trial Selection

October 11, 2010 8:18 am | News | Comments

A new lexicon that revises and unifies the definition of Alzheimer's disease to include recent developments in the field, in which biomarkers are the key to diagnosis, has been proposed by an international group of Alzheimer's disease experts.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading